BRAF and skin cancer: In a retrospective study using the multicenter skin cancer registry ADOReg of the Dermatologic Cooperative Oncology Group (DeCOG), 461 patients received first‐line BRAF or BRAF/MEK inhibitors, and 37 patients subsequently achieved CR.